Clinical presentation

Most patients are asymptomatic following apixaban or rivaroxaban poisoning; however, it is important to examine the patient for any signs of haemorrhage.

Nonhaemorrhagic complications of long-term therapy with apixaban or rivaroxaban (eg liver toxicity) are idiosyncratic and their incidence is not anticipated to be greater with poisoning.